The board of Targovax is pleased to announce Mr. Gunnar Gårdemyr as the new CEO of the company from January 12th, 2015.
Mr Gårdemyr has more than 30 years of international experience from the pharmaceutical and biotech industry. His experience includes management, business development, mergers & acquisitions, global marketing and commercial strategy.